文献速递头颈部肿瘤放疗胸部肿瘤放疗姑息放疗与转移瘤

头颈部鳞癌寡转移肺转移灶SBRT的肿瘤控制概率建模

Tumor control probability modeling of pulmonary metastases in oligometastatic head and neck squamous cell carcinoma treated with stereotactic body radiation therapy.
PubMed 文献 · Radiother Oncol · 2026-01-08

本研究针对头颈部鳞状细胞癌(HNSCC)肺转移接受立体定向体部放疗(SBRT)的患者,基于215例患者318个肺转移灶的多中心回顾数据,构建了肿瘤控制概率(TCP)模型。模型显示局部控制率呈剂量依赖性,当3次等效处方剂量和PTV D95%超过约51 Gy(BED20 94 Gy)、PTV D2%达到66 Gy(BED20 139 Gy)时,1年和2年局部控制率达95%。

要点

  • 3fxED处方剂量和PTV D95%超过约51 Gy(BED20 94 Gy)时,1年和2年局部控制率达95%。
  • PTV D2%达到66 Gy(BED20 139 Gy)时,1年和2年局部控制率达95%。
  • 所有TCP模型均显示局部控制概率随剂量增加而提高。

核心结论

  • TCP模型提示HNSCC肺转移SBRT的局部控制概率呈剂量依赖性,为后续临床评估提供依据。

研究设计与样本

  • 回顾性多中心分析,纳入215例患者的318个肺转移灶,对3fxED处方剂量、3fxED PTV D95%和3fxED PTV D2%三个剂量描述符进行剂量-时间TCP建模。

主要发现

  • 中位3fxED处方剂量为45.0 Gy(IQR 39.2-46.5),对应BED20为78.8 Gy(IQR 64.8-82.5)。
  • 中位影像随访13.3个月(IQR 6.6-32.0),共观察到21例局部失败。
  • 所有模型均显示剂量依赖性效应对局部控制概率的影响。
  • 3fxED处方剂量和PTV D95%超过约51 Gy(BED20 94 Gy)时,1年和2年局部控制率达95%。
  • PTV D2%达到66 Gy(BED20 139 Gy)时,1年和2年局部控制率达95%。

关键数值与推荐

  • 3fxED处方剂量和PTV D95%超过约51 Gy(BED20 94 Gy)对应1年和2年局部控制率95%。
  • PTV D2%达到66 Gy(BED20 139 Gy)对应1年和2年局部控制率95%。

临床怎么用

  • 模型可为HNSCC肺转移SBRT的剂量选择提供参考,但需未来临床评估验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Local control rates for pulmonary metastases from head and neck squamous cell carcinoma (HNSCC) treated with stereotactic body radiation therapy (SBRT) vary substantially in the literature, likely in part due to differences in the doses applied. This study, therefore, aims to develop tumor control probability (TCP) models. METHODS: Dose-time modeling of TCP was performed for three key dose descriptors: 3-fraction equivalent dose (3fxED) prescription dose, 3fxED planning target volume (PTV) D95%, and 3fxED PTV D2%. Each dose descriptor was stratified into 4 dose groups using a k-medians clustering algorithm, and the Kaplan-Meier estimator was computed in each group separately to enable time-dependent dose-response modeling. Logistic regression models were fitted using maximum likelihood estimation with model parameters determined separately for 1-year and 2-year local control. RESULTS: This retrospective multicenter analysis included 318 pulmonary metastases from 215 patients. The median 3fxED prescription dose was 45.0 Gy (IQR, 39.2-46.5), corresponding to a biologically effective dose (α/β = 20 Gy) (BED20) of 78.8 Gy (IQR, 64.8-82.5). After a median radiographic follow-up of 13.3 months (IQR, 6.6-32.0), 21 local failures were observed. All models indicated a dose-dependent effect on the local control probability. A local control rate of 95 % was achieved at 1 and 2 years when 3fxED prescription doses and PTV D95% exceeded about 51 Gy (94 Gy BED20), and when PTV D2% reached 66 Gy (139 Gy BED20). CONCLUSION: These TCP models suggest a dose-dependent probability of local control in pulmonary HNSCC metastases treated with SBRT and provide a basis for future clinical assessments in this population.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Ehret F, Grimm J, Subedi G, et al. Tumor control probability modeling of pulmonary metastases in oligometastatic head and neck squamous cell carcinoma treated with stereotactic body radiation therapy. Radiother Oncol. 2026. PMID: 41519167. doi:10.1016/j.radonc.2026.111375

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。